Named as a final trade on CNBC’s Halftime Report on 14 September 2026 (named as “Astrazeneca”). The price on this post is where AZN was trading at the moment the trade was named on air. A final trade is a pick made on air, and the show does not say who owns what. Nobody disclosed buying it, and the long/short on this post reflects which way the call leaned, not a position anyone took.

Also named in the same segment: EXPD at 192.72, LDOS at 133.60.

From the segment “Final Trades: Astrazeneca, Leidos Holdings, Expeditors International and the U.S. 10 year”. Watch on CNBC.

An automated tracker of public on-air picks, not a recommendation, and not affiliated with CNBC.